Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYHS1401980	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs(6)	Generic Drug	2016-07-05	辰欣药业股份有限公司	Cisen Pharmaceutical Co Ltd	Certificate Issued	2017-06-28	view
CYHS1401979	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs(6)	Generic Drug	2016-07-05	辰欣药业股份有限公司	Cisen Pharmaceutical Co Ltd	Certificate Issued	2017-06-28	view
CYHS1401978	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs(6)	Generic Drug	2016-07-05	辰欣药业股份有限公司	Cisen Pharmaceutical Co Ltd	Certificate Issued	2017-06-28	view
JYHB1901391	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs	Supplementary Application	2019-11-27	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2020-03-03	view
JYHB2001700	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs	Supplementary Application	2020-09-07	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2021-11-15	view
JYHB2001152	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs	Supplementary Application	2020-06-30	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2020-07-01	view
JYHB1901073	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs	Supplementary Application	2019-08-31	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2019-09-11	view
JYHB2001704	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs	Supplementary Application	2020-09-07	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2021-11-15	view
JYHB2001698	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs	Supplementary Application	2020-09-07	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2021-11-15	view
JYHB1901077	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs	Supplementary Application	2019-08-31	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2019-09-11	view
JYHB2001151	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs	Supplementary Application	2020-06-30	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2020-07-01	view
JYHB1901072	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs	Supplementary Application	2019-08-31	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2019-09-11	view
JYHB1901080	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs	Supplementary Application	2019-08-31	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2019-09-11	view
JYHB2001703	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs	Supplementary Application	2020-09-07	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2021-11-15	view
JYHB1901076	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs	Supplementary Application	2019-08-31	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2019-09-11	view
JYHB2001706	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs	Supplementary Application	2020-09-07	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2021-11-15	view
JYHB1901079	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs	Supplementary Application	2019-08-31	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2019-09-11	view
JYHB1901392	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs	Supplementary Application	2019-11-28	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2020-03-03	view
JYHB2001702	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs	Supplementary Application	2020-09-07	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2021-11-15	view
JYHB1901075	达肝素钠注射液	dalteparin sodium	Injection	Chemical Drugs	Supplementary Application	2019-08-31	辉瑞投资有限公司	Pfizer Investment Co Ltd	Filed	2019-09-11	view